Report Overview:
Lansoprazole injection is a formulation of the medication lansoprazole that is administered intravenously (IV) or intramuscularly (IM). Lansoprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. It is commonly used to treat conditions such as ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.
This report provides a deep insight into the global Lansoprazole for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
Market Value:
The global Lansoprazole for Injection market size was estimated at USD 193 million in 2024 and is projected to reach USD 362.56 million by 2032, exhibiting a CAGR of 8.20% during the forecast period. CAGR of 8.20% (2025 – 2032)
By Types:
• Vial Type
• Ampule Type
By Applications:
Male
Female
Key players include:
• Takeda
• Maya Biotech
• Luoxin Pharmaceutical
• Yuekang Pharmaceutical
• Jiangsu Aosaikang Pharmaceutical
• Chengdu Baiyu Pharmaceutical
• Including or Excluding key companies relevant to your analysis.
